Coronavirus disease 19 (COVID-19) is a new pandemic that has affected more than 80 million people. COVID-19 is caused by a new coronavirus strain, acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 may range from asymptomatic to severe acute respiratory syndrome and coagulative disorder, causing the death of up to 3% of patients (1). However, significant differences exist between countries concerning the incidence, spread, severity, and mortality rates (2).
Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study
I. La MantiaConceptualization
;
2021-01-01
Abstract
Coronavirus disease 19 (COVID-19) is a new pandemic that has affected more than 80 million people. COVID-19 is caused by a new coronavirus strain, acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 may range from asymptomatic to severe acute respiratory syndrome and coagulative disorder, causing the death of up to 3% of patients (1). However, significant differences exist between countries concerning the incidence, spread, severity, and mortality rates (2).File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects_ a pilot study.pdf
solo gestori archivio
Descrizione: LETTER TO EDITOR
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
235.79 kB
Formato
Adobe PDF
|
235.79 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.